Oraquick Rapid News Today

OraSure Technologies (NASDAQ:OSUR – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a report released on Wednesday. Separately, Evercore ISI cut their target price on shares of OraSure Technologies from $7.00 to $6.50 and set an “in-line” rating on the stock in a report on Thursday, April […]

StockNews.com upgraded shares of OraSure Technologies (NASDAQ:OSUR – Free Report) from a hold rating to a buy rating in a report issued on Wednesday. Separately, Evercore ISI cut their price target on shares of OraSure Technologies from $7.00 to $6.50 and set an in-line rating on the stock in a report on Thursday, April 4th. […]

OraSure Technologies (NASDAQ:OSUR – Get Free Report) and IceCure Medical (NASDAQ:ICCM – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Valuation & Earnings This table compares OraSure […]

In 2020, almost 20% of people living with HIV (PLHIV) in Morocco are still unaware of their HIV status. Under these circumstances, HIV self-test (HIVST) can be an efficient additional tool for improving the testing rates in Morocco and reaching the first objective of the UNAIDS 95–95-95 goal. ALCS, a Community-based organization, involved in HIV Testing since 1992, and the Ministry of Health of Morocco conducted, a study on the acceptability and usability of HIVST among Female sex workers ...

Brokerages expect OraSure Technologies, Inc. (NASDAQ:OSUR – Get Rating) to announce ($0.14) earnings per share (EPS) for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for OraSure Technologies’ earnings. The lowest EPS estimate is ($0.20) and the highest is ($0.07). OraSure Technologies reported earnings per share of ($0.02) in the same […]

OraSure Technologies (NASDAQ:OSUR – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Thursday, Zacks.com reports. According to Zacks, “OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays […]

Analysts expect OraSure Technologies, Inc. (NASDAQ:OSUR – Get Rating) to announce $64.74 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for OraSure Technologies’ earnings, with the highest sales estimate coming in at $68.30 million and the lowest estimate coming in at $62.22 million. OraSure Technologies posted […]

Analysts forecast that OraSure Technologies, Inc. (NASDAQ:OSUR – Get Rating) will announce sales of $64.74 million for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for OraSure Technologies’ earnings, with the lowest sales estimate coming in at $62.22 million and the highest estimate coming in at $68.30 million. OraSure […]

Shares of OraSure Technologies, Inc. (NASDAQ:OSUR – Get Rating) have been given an average recommendation of “Hold” by the six brokerages that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the […]

Lucid Diagnostics (NASDAQ:LUCD – Get Rating) and OraSure Technologies (NASDAQ:OSUR – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Analyst Ratings This is a summary of current ratings […]